Delafloxacin Meglumine Patent Expiration

Delafloxacin Meglumine is used for treating acute bacterial skin infections in adults. It was first introduced by Melinta Subsidiary Corp in its drug Baxdela on Jun 19, 2017.


Delafloxacin Meglumine Patents

Given below is the list of patents protecting Delafloxacin Meglumine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Baxdela US12036219 Methods of treating infections in overweight and obese patients using antibiotics Jun 02, 2034 Melinta
Baxdela US9493582 Alkylated cyclodextrin compositions and processes for preparing and using the same Feb 27, 2033 Melinta
Baxdela US7728143 Salt and crystalline forms thereof of a drug Jun 19, 2031 Melinta
Baxdela US8497378 Process for making quinolone compounds Dec 28, 2029 Melinta
Baxdela USRE46617 Process for making quinolone compounds Dec 28, 2029 Melinta
Baxdela US8871938 Process for making quinolone compounds Sep 23, 2029 Melinta
Baxdela US7635773 Sulfoalkyl ether cyclodextrin compositions Mar 13, 2029 Melinta
Baxdela US8410077 Sulfoalkyl ether cyclodextrin compositions Mar 13, 2029 Melinta
Baxdela US9200088 Sulfoalkyl ether cyclodextrin compositions Mar 13, 2029 Melinta
Baxdela US9750822 Sulfoalkyl ether cyclodextrin compositions Mar 13, 2029 Melinta
Baxdela US8252813 Salt and crystalline forms thereof of a drug Oct 02, 2026 Melinta
Baxdela US8273892 Salt and crystalline forms thereof of a drug Aug 06, 2026 Melinta
Baxdela US8648093 Salt and crystalline forms thereof of a drug Oct 07, 2025 Melinta
Baxdela US8969569 Salt and crystalline forms thereof of a drug Oct 07, 2025 Melinta
Baxdela US9539250 Salt and crystalline forms thereof of a drug Oct 07, 2025 Melinta



Delafloxacin Meglumine's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List